Table 3.
Biochemical, inflammatory and anthropometric parameters in the T2DM patient groups with low and high polyphenol or PUFAs omega 3 intakes.
| Polyphenols | PUFAs Omega 3 | |||
|---|---|---|---|---|
| low | high | low | high | |
| FG (mg/dL) | 127 (113; 155) | 119 (108; 138) | 122 (112; 157) | 121 (108; 138) |
| HbA1c (%) | 6.5 (5.9; 7.3) | 6.4 (6.0; 6.9) | 6.6 (6.0; 7.5) | 6.4 (5.9; 6.8) * |
| TCH (mg/dL) | 180 (144; 207) | 185 (149; 213) | 185 (152; 216) | 177 (145; 201) |
| LDL-TCH (mg/dL) | 100 (73; 132) | 103 (79; 124) | 101 (75; 125) | 102 (76; 131) |
| HDL-CH (mg/dL) | 47 (41; 55) | 49 (40; 61) | 49 (40; 55) | 49 (40; 61) |
| TG (mg/dL) | 141 (104; 201) | 138 (103; 178) | 138 (108; 199) | 139 (101; 174) |
| PLR | 114 (91; 139) | 106 (85; 142) | 107 (82; 131) | 119 (89; 142) |
| NLR | 2.2 (1.6; 2.8) | 2.2 (1.6; 2.9) | 2.2 (1.5; 2.9) | 2.2 (1.6; 2.9) |
| MPVLR | 5.0 (4.1; 6.2) | 4.6 (4.0; 5.9) | 5.2 (4.0; 6.0) | 4.8 (4.1; 6.3) |
| BMI (kg/m2) | 31.2 (28.3; 35.2) | 34.0 (27.1; 38.1) | 33.0 (28.1; 35.9) | 32.0 (28.2; 36.9) |
| waist circumference (cm) | 108 (102; 115) | 111 (101; 119) | 110 (101; 118) | 108 (102; 117) |
| WHR | 0.96 (0.91; 1.01) | 0.97 (0.92; 1.02) | 0.97 (0.91; 1.02) | 0.96 (0.92;1.02) |
Data are shown as median (MD) and interquartile range (Q1; Q3). The significance level of HbA1c was observed for high PUFAs omega 3 intakes compared to PUFAs omega 3 low intakes, * p < 0.05. FG- fasting glucose concentration; HbA1c—glycated haemoglobin; TCH—total cholesterol; HDL-CH—HDL-cholesterol; LDL-CH—LDL-cholesterol; TG—triglycerides; MPVLR—mean platelet volume-to-lymphocyte ratio; NLR—neutrophil-to-lymphocyte ratio; PLR—platelet-to-lymphocyte ratio; BMI—body mass index; WHR—waist-to-hip ratio.